Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6677266 | 7323128 | F | 2 | 6677266-0 | 20091201 | 20100323 | 20100408 | EXP | THQ2010A00433 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 49 | YR | F | N | 20100407 | OT | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6677266 | 1013484334 | PS | ACTOS | 1 | 15 MG (15 MG,1 IN 1 D) | Y | U | 21073 | |||
| 6677266 | 1013543881 | SS | BYETTA | 1 | SUBCUTANEOUS | SEE IMAGE | |||||
| 6677266 | 1013543882 | SS | GLUCOPHAGE | 1 | 2.55 GM (2.55 GM,1 IN 1 D) ; 2.55 GM (2.55 GM,1 IN 1 D) |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6677266 | 1013484334 | TYPE 2 DIABETES MELLITUS |
| 6677266 | 1013543881 | TYPE 2 DIABETES MELLITUS |
| 6677266 | 1013543882 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6677266 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6677266 | ABDOMINAL PAIN LOWER |
| 6677266 | SALPINGO-OOPHORECTOMY BILATERAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6677266 | FGN |
| 6677266 | HP |
| 6677266 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6677266 | 1013484334 | 20091112 | 20091201 | 19 | DAY |
| 6677266 | 1013543881 | 20070524 | 20070621 | 28 | DAY |
| 6677266 | 1013543881 | 20070622 | 20091201 | 893 | DAY |
| 6677266 | 1013543881 | 20091203 | |||
| 6677266 | 1013543882 | 20060501 | 20091201 | 3 | YR |
| 6677266 | 1013543882 | 20091203 |